2021 Archive

Learn about the mRNA-targeting therapy

Meet Layne Pullen, a researcher within the Preclinical Therapeutics Program.

See how St. Jude is bridging the gap between classroom learning and real-world workforce demands.

Meet Saikat Nandy, PhD, and learn about his journey from actuarial science to education and training. 

Learn about Susan Lea’s research on how bacteria interact with their hosts.

Meet Meghan B. Ward, PhD, who has gone from researching molecules to designing a clinical trial at St. Jude.

Explore new research uncovering the connection and how it may help patients break out of negative cycles.

See how St. Jude Global is creating a ripple effect that strengthens pediatric cancer care worldwide.

Learn how St. Jude is embracing another frontier in structural biology

Meet Katelyn Daniels, MD, a Pediatric Hematology/Oncology fellow whose desire to improve patient outcomes led her to pursue a Physician Scientist Instructor position

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.